Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1999The Journal of Infectious Diseases

A Direct Comparison of the Activities of Two Humanized Respiratory Syncytial Virus Monoclonal Antibodies: MEDI‐493 and RSHZl9

View Full Paper
Ask AI
Bookmark
Share

Authors

SJSyd JohnsonAmerican College of Allergy, Asthma and ImmunologySGSandra D. GriegoGlaxoSmithKline (United States)DPDavid S. PfarrUniformed Services University of the Health Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Johnson et al. (1999) studied this question.

synapsesocial.com/papers/6a2010ea2065d284090de64ehttps://doi.org/10.1086/314846
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus1997 · 648 citations
  2. 2Respiratory syncytial virus infection and the immunocompromised host1988 · 37 citations
  3. 3Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function1989 · 297 citations
  4. 4Respiratory Syncytial Virus Infection in Children With Bronchopulmonary Dysplasia1988 · 378 citations